Clinical Trials Directory

Trials / Completed

CompletedNCT06776185

Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma

Recurrence Patterns and Cost-Effectiveness of Robotic-assisted, Laparoscopic, and Open Liver Resection in BCLC 0/A Hepatocellular Carcinoma:

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Chen Xiaoping · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the recurrence patterns and cost-effectiveness of robotic-assisted, laparoscopic, and open liver resections in patients with early-stage (BCLC 0/A) hepatocellular carcinoma. By analyzing data from 3000 patients across 27 centers, the research evaluates recurrence-free survival, overall survival, and long-term economic impacts using metrics such as quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). Findings will provide insights into optimal surgical approaches to improve patient outcomes and healthcare resource utilization.

Conditions

Interventions

TypeNameDescription
PROCEDURELiver SurgeryMinimally Invasive Liver Resection In both LLR and RALR, standardized preoperative planning with 3D imaging was utilized to assess tumor location, size, and proximity to vascular structures, enabling precise port placement. Typically, four to five trocar ports were inserted based on the tumor's location, with adjustments as needed

Timeline

Start date
2022-01-15
Primary completion
2024-11-15
Completion
2024-11-15
First posted
2025-01-15
Last updated
2025-01-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06776185. Inclusion in this directory is not an endorsement.